Seeking Alpha Quant rates LABU as a strong Sell, but I rates it as a Buy due to bullish market conditions. LABU is a leveraged ETF that seeks to track 3x the daily performance of the S&P Biotechnology ...
Investors in Direxion Shares Exchange Traded Fund Trust - Direxion Daily S&P Biotech Bull 3X Shares (Symbol: LABU) saw new options begin trading today, for the February 24th expiration. At Stock ...
Investors in Direxion Shares Exchange Traded Fund Trust - Direxion Daily S&P Biotech Bull 3X Shares (Symbol: LABU) saw new options become available today, for the June 2nd expiration. At Stock Options ...
The Direxion Daily S&P Biotech Bull and Bear 3X Shares (LABU) provides 3x daily exposure to a biotechnology index. Levered ETFs like LABU are designed for short-term trading and may suffer tracking ...
Direxion Daily S&P Biotech Bull 3X Shares has no upcoming dividends reported. The last reported dividend for Direxion Daily S&P Biotech Bull 3X Shares (LABU) was $0.22 and was paid out on July 1, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results